America’s biotech company Moderna has said that if the vaccine available in the market does not affect the new variant of Corona, Omicron, then in such a situation a new vaccine will have to be made at the beginning of next year. Moderna’s chief medical officer Paul Burton said it remains to be seen whether the available vaccine is effective for Omicron.
The company has issued a press release saying that it is rapidly examining the effectiveness of the existing vaccine on the Omicron variant.
